Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.38 - $9.02 $1.12 Million - $2.3 Million
255,000 Added 130.77%
450,000 $3.02 Million
Q4 2023

Feb 14, 2024

SELL
$4.06 - $10.08 $1.85 Million - $4.59 Million
-455,000 Reduced 70.0%
195,000 $1.15 Million
Q3 2023

Nov 14, 2023

BUY
$9.69 - $13.34 $726,750 - $1 Million
75,000 Added 13.04%
650,000 $6.34 Million
Q2 2023

Aug 14, 2023

BUY
$9.85 - $13.24 $246,250 - $331,000
25,000 Added 4.55%
575,000 $6.81 Million
Q1 2023

May 15, 2023

SELL
$10.04 - $15.5 $2.51 Million - $3.88 Million
-250,000 Reduced 31.25%
550,000 $5.93 Million
Q4 2022

Feb 14, 2023

BUY
$10.65 - $14.84 $2.13 Million - $2.97 Million
200,000 Added 33.33%
800,000 $9.25 Million
Q3 2022

Nov 14, 2022

SELL
$9.39 - $16.99 $2.82 Million - $5.1 Million
-300,000 Reduced 33.33%
600,000 $8.95 Million
Q2 2022

Aug 15, 2022

SELL
$3.92 - $9.73 $3.14 Million - $7.78 Million
-800,000 Reduced 47.06%
900,000 $8.12 Million
Q4 2021

Feb 16, 2022

BUY
$7.51 - $10.81 $1.5 Million - $2.16 Million
200,000 Added 13.33%
1,700,000 $14.6 Million
Q3 2021

Nov 15, 2021

SELL
$5.99 - $9.14 $599,000 - $914,000
-100,000 Reduced 6.25%
1,500,000 $12.6 Million
Q1 2021

May 14, 2021

BUY
$7.47 - $12.34 $3.74 Million - $6.17 Million
500,000 Added 45.45%
1,600,000 $14 Million
Q4 2020

Feb 16, 2021

BUY
$9.04 - $13.01 $9.94 Million - $14.3 Million
1,100,000 New
1,100,000 $12.4 Million

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $585M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.